Myeloid-Targeted Immunotherapies Act in Synergy to Induce Inflammation and Antitumor Immunity

Journal of Experimental Medicine - United States
doi 10.1084/jem.20171435
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Rockefeller University Press

Related search

Novel Cancer Immunotherapies and Antitumor Immunity

Journal of Immunology Research
MedicineAllergyImmunology
2019English

Toll-Like Receptor Triggering and T-Cell Costimulation Induce Potent Antitumor Immunity in Mice

Clinical Cancer Research
Cancer ResearchOncology
2009English

Antibodies Targeted to TRAIL Receptor-2 and ErbB-2 Synergize in Vivo and Induce an Antitumor Immune Response

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

More Than Complementing Tolls: Complement-Toll-Like Receptor Synergy and Crosstalk in Innate Immunity and Inflammation

Immunological Reviews
AllergyImmunology
2016English

Catechins and Antitumor Immunity

OncoImmunology
OncologyAllergyImmunology
2013English

Immunological and Translational Aspects of NK Cell-Based Antitumor Immunotherapies

Frontiers in Immunology
AllergyImmunology
2016English

Reprogramming Antitumor Immunity

Trends in Immunology
AllergyImmunology
2014English

Antagonism of VEGF by Genetically Engineered Dendritic Cells Is Essential to Induce Antitumor Immunity Against Malignant Ascites

Molecular Cancer Therapeutics
Cancer ResearchOncology
2011English

NRF2 Regulates HER2 and HER3 Signaling Pathway to Modulate Sensitivity to Targeted Immunotherapies

Oxidative Medicine and Cellular Longevity
BiochemistryMedicineCell BiologyAging
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy